Issue |
Vis Cancer Med
Volume 3, 2022
|
|
---|---|---|
Article Number | 4 | |
Number of page(s) | 4 | |
DOI | https://doi.org/10.1051/vcm/2022005 | |
Published online | 21 October 2022 |
Perspective Article
Benefits of precision medicine in lung cancer: experience from a single institution
Precision Medicine Center of Oncology, the Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266016, China
* Corresponding author: zxc9670@qdu.edu.cn
Received:
13
July
2022
Accepted:
16
September
2022
Lung cancer remains the leading cause of cancer death worldwide and in China. Over the past two decades, targeted therapy and immunotherapy have improved the five-year survival rate of lung cancer, and precision medicine has played a great part in this progress. However, owing to the heterogeneity, complexity, and economic disparity, the usage of precision medicine is still low, which generally results in a poor prognosis. In view of the current bottlenecks, such as low early diagnosis rates and the poor prognosis of lung cancer patients, our team predicted and identified early diagnosis markers of lung cancer. We have described the genetic characteristics of lung cancer patients, identified potential treatment targets, and explored accurate treatment schemes for the disease. We have also promoted their application by conducting bioinformatic analysis, high-throughput sequencing, liquid biopsy, and improved FISH and other technologies. This has formed an integrated system for the precise diagnosis, treatment, and transformation of lung cancer research, obtaining good social benefits after their application.
Key words: Precision medicine / Lung cancer / Integrated system
© The Authors, published by EDP Sciences, 2022
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.